Business ❯ Biotechnology ❯ Clinical Trials

Regulatory Affairs

FDA Approval Process FDA Designations

FDA Rejects Replimune’s Melanoma Virus Therapy Again for Insufficient Evidence

The decision underscores the FDA’s insistence on well‑controlled efficacy data over single‑arm results.

FDA Grants Priority Review to Vera's Atacicept for IgA Nephropathy